ArticleBlood advances2025
Hematopoietic progenitor kinase-1 inhibition improves the in vitro efficacy of bispecific antibodies in CLL.
Yamit Shorer Arbel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleBlood advances2025
Yamit Shorer Arbel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.